Risk of death and thrombosis in patients admitted to the emergency department with supraventricular tachycardias

Tommaso Bucci; Luigi Gerra; Steven Ho Man Lam; Antonis Argyris; Giuseppe Boriani; Riccardo Proietti; Arnaud Bisson; Laurent Fauchier; Professor Gregory Lip

doi:10.1016/j.hrthm.2024.11.044

Abstract

1 min read

The increased risk of adverse events in patients with SVT appears to be most pronounced in the short term and partly associated with the increased likelihood of incident AF.

Related publications

Article2023

Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices

So-Ryoung Lee, Ji Hyun Lee, Eue-Keun Choi, Eun‐Kyung Jung, So-Jeong You, Seil Oh, Professor Gregory Lip

Article2025

Long-term risk of adverse events in patients discharged alive after hospitalization for hypertensive crisis

Tommaso Bucci, Steven Ho Man Lam, Antonis Argyris, DG Beevers, Eduard Shantsila, Alena Shantsila, Professor Gregory Lip

Article2022

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation

So-Ryoung Lee, Eue‐Keun Choi, Sang-Hyeon Park, Seung‐Woo Lee, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2011

Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study

Kirsten van Langevelde, Willem M. Lijfering, Frits R. Rosendaal, Suzanne C. Cannegieter

Blood

Article2007

Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis

Sarwa Darwish Murad, Moniek P.M. de Maat, Michael W.T. Tanck, E. B. Haagsma, Bart van Hoek, Frits R. Rosendaal, Harry L.A. Janssen, Frank W.G. Leebeek, Emile de Bruijne

Thrombosis and Haemostasis